This randomized controlled trial (RCT) was undertaken to evaluate the effect of vibroacoustic stimulation (VAS) on the fetal heart rate tracing, mode of delivery and perinatal outcomes, when cardiotocographs (CTG) showed non-reassuring features during labour. In this RCT, 60 women beyond 30 weeks' gestation in labour having non reassuring CTG for 20 min were recruited in either study group (VAS group) or control group (non-VAS group). Women in the study group received VAS for 3 sec up to 3 occasions at an interval of 1 to 3 min while the control group received no VAS. There were significant improvement of baseline variability and acceleration in both VAS and control group during second 20 min (P<0.001). Although these improvements were more evident in VAS group, the difference between the two groups were not statistically significant (P>0.05). However, in VAS group, there was 3 min less testing time required to achieve reassuring CTG features (2.6 versus 5.6 min), and a tendency to have less cesarean delivery (60% versus 55.2%; p>0.05). Perinatal outcomes were similar in both groups. There is a trend toward less number of caesarean section in VAS group, probably because of early and more acquisition of reassuring CTG features. Therefore, this study suggests that VAS is potentially beneficial in women with suspicious CTG. Considering the procedure simple, safe and less expensive, it would be prudent to use VAS during CTG monitoring, especially in low resource countries, where facilities for fetal blood sampling is not widely available.